Phase III clinical trials have demonstrated the viability of intermittent hormone therapy in many patients with advanced prostate cancer -- this means that patients with undetectable PSAs who, in the past, would have been treated with hormone therapy for the rest of their lives can now consider...
https://rally.massgeneralbrigham.org/study/prostatecancersurvivors
Brigham and Women's Hospital is conducting this study to research whether testosterone replacement therapy improves the quality of life for men who have undergone prostate removal for prostate cancer.
Overview
What we are...
Dr. Jason Sandberg details the role that testosterone plays in prostate cancer in @MIUMensHealthFoundation's Prostate Cancer Survivorship Series event "Sexuality After Prostate Cancer- A New Beginning".
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.